EMIS — EMIS Income Statement
0.000.00%
Last trade - 00:00
HealthcareAdventurousMid Cap
- £1.23bn
- £1.19bn
- £175.37m
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 150 | 160 | 159 | 168 | 175 |
Cost of Revenue | |||||
Gross Profit | 135 | 144 | 139 | 152 | 162 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 122 | 133 | 123 | 132 | 148 |
Operating Profit | 27.7 | 26.8 | 36.6 | 35.8 | 27.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 28.1 | 27.1 | 36.9 | 36.1 | 38.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.8 | 22 | 30.1 | 29.1 | 33.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 22.7 | 22.7 | 30.2 | 29.1 | 33.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 22.7 | 22.7 | 30.2 | 29.1 | 33.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.325 | 0.423 | 0.479 | 0.456 | 0.677 |
Dividends per Share |